OxyHeal Health Group®, over the past 30 years, has conducted or participated in Hyperbaric and diving research involving animal studies, human studies, and equipment research. Most recently, members of the OxyHeal Health Group® have developed, engineered, built and patent-protected the first Hyperbaric incubator, the OxyCure® 3000, in order to conduct genetic research in cellular biology studies. Two of the worlds leading university medical centers are currently conducting studies with the OxyCure® 3000. OxyHeal® is fully committed to the support of research to extend the field of Hyperbaric medicine and its uses of high dose oxygen to cure and better treat future and current modalities. |
|||